C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 19/00 (2006.01) A61K 38/16 (2006.01) A61K 47/48 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01) C07K 14/605 (2006.01) C07K 16/18 (2006.01)
Patent
CA 2718480
The present invention relates to drug fusions that have improved serum half lives. These fusions and conjugates comprise polypeptides, immunoglobulin (antibody) single variable domains and GLP and/or exendin molecules. The invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates.
La présente invention concerne des fusions médicamenteuses qui présentent des demi-vies sériques améliorées. Ces fusions et ces conjugués comprennent des polypeptides, des domaines variables uniques (anticorps) de limmunoglobuline et des GLP et/ou des molécules dexendin. Linvention porte en outre sur des utilisations, des formulations, des compositions et des dispositifs comprenant de telles fusions médicamenteuses et de tels conjugués médicamenteux.
Hamilton Bruce
Herring Christopher
Holt Lucy J.
Jespers Laurent
Glaxo Group Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Drug fusions and conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug fusions and conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug fusions and conjugates will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1892874